DUS3L Activators
Chemical activators of DUS3L can facilitate the protein's activation through various mechanisms, primarily centered around the modulation of the cAMP-PKA signaling pathway. Forskolin directly stimulates adenylate cyclase, the enzyme responsible for converting ATP to cAMP, thereby raising intracellular cAMP levels. This surge in cAMP activates protein kinase A (PKA), which then phosphorylates target proteins such as DUS3L, initiating its activation. Similarly, IBMX, by inhibiting phosphodiesterases, prevents the degradation of cAMP, leading to its accumulation within the cell. This accumulation has the same downstream effect of activating PKA, which in turn can activate DUS3L.
Several endogenous ligands, such as epinephrine, isoproterenol, PGE1, histamine, dopamine, norepinephrine, and glucagon, bind to and activate their respective G protein-coupled receptors (GPCRs). This receptor activation prompts adenylate cyclase to synthesize more cAMP from ATP. The rise in cAMP levels results in PKA activation, leading to the phosphorylation of DUS3L. In a slightly different mechanism, cholera toxin targets the Gs alpha protein directly, locking it in an active state that continuously stimulates adenylate cyclase, thus producing high cAMP levels and leading to prolonged PKA activation and sustained phosphorylation of DUS3L. PACAP-38 engages with PAC1 receptors, also culminating in adenylate cyclase activation and increased cAMP, thereby activating PKA which then phosphorylates DUS3L. Finally, anagrelide elevates cAMP by inhibiting phosphodiesterase III, following the common pathway of PKA-mediated phosphorylation to activate DUS3L. Each of these chemicals, through their unique interactions with cellular signaling components, converges on the cAMP-PKA pathway to facilitate the activation of DUS3L.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to an increase in cAMP levels by preventing its breakdown. Elevated cAMP activates PKA, which in turn can phosphorylate and activate DUS3L. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can trigger a signaling cascade resulting in the activation of adenylate cyclase and subsequent increase in cAMP levels. This elevation of cAMP activates PKA, which could phosphorylate and activate DUS3L. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic beta-adrenergic agonist that activates adenylate cyclase through interaction with beta-adrenergic receptors, leading to increased production of cAMP and activation of PKA, which may then activate DUS3L. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Prostaglandin E1 (PGE1) binds to its E-prostanoid receptors, which are coupled to adenylate cyclase activation. The resultant rise in cAMP levels leads to the activation of PKA, which can activate DUS3L. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, when interacting with H2 receptors, increases intracellular cAMP levels by activating adenylate cyclase. Elevated cAMP activates PKA, which can then activate DUS3L through phosphorylation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to D1-like receptors which activate adenylate cyclase, leading to increased cAMP levels. The cAMP activates PKA and can lead to the phosphorylation and activation of DUS3L. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Pituitary adenylate cyclase-activating polypeptide (PACAP-38) binds to PAC1 receptors which activates adenylate cyclase, increasing cAMP levels. The increased cAMP activates PKA, which may activate DUS3L. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine, through its interaction with beta-adrenergic receptors, can activate adenylate cyclase, resulting in increased cAMP and PKA activation. PKA may then activate DUS3L. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide increases cAMP levels by inhibiting phosphodiesterase III. The increased cAMP levels activate PKA, which can potentially phosphorylate and activate DUS3L. | ||||||